Treatment patterns of patients with HR+/HER2- metastatic breast cancer receiving CDK4/6 inhibitor-based regimens: a cohort study in the French nationwide healthcare database

被引：0
作者：
Stephanie H. Read
Nadia Quignot
Raissa Kapso-Kapnang
Erin Comerford
Ying Zheng
Corona Gainford
Medha Sasane
Anne-Lise Vataire
Laure Delzongle
Francois-Clement Bidard
机构：
[1] Certara UK Limited,Department of Medical Oncology
[2] Certara France,undefined
[3] Sanofi,undefined
[4] Sanofi,undefined
[5] Institut Curie,undefined
[6] Université Versailles Saint-Quentin,undefined
[7] Université Paris-Saclay,undefined
来源：
Breast Cancer Research and Treatment | 2024年 / 204卷
关键词：
Hormone receptor negative; Metastatic breast cancer; Endocrine therapy; Cyclin-dependent kinase 4/6 inhibitor; Real-world evidence; SNDS;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：579 / 588
页数：9
相关论文
共 50 条
[41]   Treatment patterns and outcomes associated with sequential and non-sequential use of CDK4 & 6 inhibitors in patients with HR+, HER2-MBC in the real world [J].
Kruse, Megan ;
Smyth, Emily Nash ;
Bowman, Lee ;
Gautam, Santosh ;
Guimaraes, Claudia M. ;
Nisbett, Alnecia R. ;
Fisher, Maxine D. ;
Cui, Zhanglin Lin ;
Sheffield, Kristin M. ;
Kalinsky, Kevin .
BREAST CANCER RESEARCH AND TREATMENT, 2023, 201 (01) :105-115
[42]   Treatment patterns and outcomes associated with sequential and non-sequential use of CDK4 & 6 inhibitors in patients with HR+, HER2− MBC in the real world [J].
Megan Kruse ;
Emily Nash Smyth ;
Lee Bowman ;
Santosh Gautam ;
Claudia M. Guimaraes ;
Alnecia R. Nisbett ;
Maxine D. Fisher ;
Zhanglin Lin Cui ;
Kristin M. Sheffield ;
Kevin Kalinsky .
Breast Cancer Research and Treatment, 2023, 201 :105-115
[43]   Impact of HER2-low expression on the efficacy of endocrine therapy with or without CDK4/6 inhibitor in HR-positive/HER2-negative metastatic breast cancer: A prospective study [J].
Wu, Yun ;
Mo, Hongnan ;
Xu, Hangcheng ;
Wang, Yan ;
Wang, Jiayu ;
Ma, Fei ;
Xu, Binghe .
THORACIC CANCER, 2024, 15 (12) :965-973
[44]   Is there a role for continuation of CDK4/6 inhibition after progression on a prior CDK4/6 inhibitor in HRD/HER2L metastatic breast cancer? [J].
Giordano, A. ;
Lin, N. U. ;
Tolaney, M. ;
Mayer, L. .
ANNALS OF ONCOLOGY, 2024, 35 (01) :10-14
[45]   HR+, HER2-Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of Action, Clinical Activity, and Safety Profiles [J].
Sammons, Sarah L. ;
Topping, Donna L. ;
Blackwell, Kimberly L. .
CURRENT CANCER DRUG TARGETS, 2017, 17 (07) :637-649
[46]   Abemaciclib: The First FDA-Approved CDK4/6 Inhibitor for the Adjuvant Treatment of HR+HER2-Early Breast Cancer [J].
Raheem, Farah ;
Ofori, Henry ;
Simpson, Lacey ;
Shah, Vishal .
ANNALS OF PHARMACOTHERAPY, 2022, 56 (11) :1258-1266
[47]   Is the percentage of hormone receptor positivity in HR+HER2-metastatic breast cancer patients receiving CDK 4/6 inhibitor with endocrine therapy predictive and prognostic? [J].
Keskinkilic, Merve ;
Semiz, Huseyin Salih ;
Yavuzsen, Tugba ;
Oztop, Ilhan .
FRONTIERS IN ONCOLOGY, 2024, 14
[48]   Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in breast cancer patients [J].
Abena Minta ;
Lucy Rose ;
Candice Park ;
Bhuvaneswari Ramaswamy ;
Daniel Stover ;
Margaret Gatti-Mays ;
Mathew Cherian ;
Nicole Williams ;
Preeti Sudheendra ;
Robert Wesolowski ;
Sagar Sardesai ;
Maryam Lustberg ;
Charles L. Loprinzi ;
Kathryn J. Ruddy ;
Elizabeth Cathcart-Rake ;
Stephanie Trovato ;
Brittany Dulmage .
Supportive Care in Cancer, 2023, 31
[49]   Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in breast cancer patients [J].
Minta, Abena ;
Rose, Lucy ;
Park, Candice ;
Ramaswamy, Bhuvaneswari ;
Stover, Daniel ;
Gatti-Mays, Margaret ;
Cherian, Mathew ;
Williams, Nicole ;
Sudheendra, Preeti ;
Wesolowski, Robert ;
Sardesai, Sagar ;
Lustberg, Maryam ;
Loprinzi, Charles L. ;
Ruddy, Kathryn J. ;
Cathcart-Rake, Elizabeth ;
Trovato, Stephanie ;
Dulmage, Brittany .
SUPPORTIVE CARE IN CANCER, 2023, 31 (12)
[50]   Single-cell RNA sequencing identifies molecular biomarkers predicting late progression to CDK4/6 inhibition in patients with HR+/HER2-metastatic breast cancer [J].
Luo, Linjie ;
Yang, Peng ;
Mastoraki, Sofia ;
Rao, Xiayu ;
Wang, Yan ;
Kettner, Nicole M. ;
Raghavendra, Akshara Singareeka ;
Tripathy, Debasish ;
Damodaran, Senthil ;
Hunt, Kelly K. ;
Wang, Jing ;
Li, Ziyi ;
Keyomarsi, Khandan .
MOLECULAR CANCER, 2025, 24 (01)
12345